ImmunoGen Inc IMGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:24 PM EDT
5.10quote price arrow up+0.20 (+4.08%)
Volume
3,402,590
52 week range
3.10 - 7.77
Loading...
  • Open4.90
  • Day High5.29
  • Day Low4.90
  • Prev Close4.90
  • 52 Week High7.77
  • 52 Week High Date12/01/21
  • 52 Week Low3.10
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap1.125B
  • Shares Out220.54M
  • 10 Day Average Volume3.87M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change-31.33

KEY STATS

  • Open4.90
  • Day High5.29
  • Day Low4.90
  • Prev Close4.90
  • 52 Week High7.77
  • 52 Week High Date12/01/21
  • 52 Week Low3.10
  • 52 Week Low Date06/14/22
  • Market Cap1.125B
  • Shares Out220.54M
  • 10 Day Average Volume3.87M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change-31.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.60
  • P/E (TTM)-8.50
  • Fwd P/E (NTM)-5.43
  • EBITDA (TTM)-117.07M
  • ROE (TTM)-64.60%
  • Revenue (TTM)92.23M
  • Gross Margin (TTM)76.15%
  • Net Margin (TTM)-140.30%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date07/28/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ImmunoGen Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ImmunoGen, Inc. is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company’s technology comprises an antibody that binds to a target found on tumor cells and is conjugated to one of its potent anti-cancer agents as a payload to kill the tumor cell once the ADC has bound to its target. Its product candidates include Mirvetuximab soravtansine (IMGN853), IMGN632, MGC936 and...
Stephen Mccluski
Independent Chairman of the Board
Mark Enyedy J.D.
President, Chief Executive Officer, Director
Susan Altschuller Ph.D.
Chief Financial Officer, Senior Vice President
Address
830 Winter Street
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
ENTA
Enanta Pharmaceuticals Inc
51.70-0.98-1.87%
RVNC
Revance Therapeutics Inc
14.45-0.28-1.90%
NGM
NGM Biopharmaceuticals Inc
14.31+0.32+2.25%
MNKD
MannKind Corp
4.14+0.10+2.35%
PACB
Pacific Biosciences of California Inc
5.17-0.02-0.48%